| 1 |
Valentijn RM, Radl J, Haaijman JJ, et al. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy [J]. Kidney Int, 1984, 26(5): 760-766.
|
| 2 |
Novak J, Julian BA, Tomana M, et al. Progress in molecular and genetic studies of IgA nephropathy [J]. J Clin Immunol, 2001, 21(5): 310-327.
|
| 3 |
Tomino Y, Sakai H, Miura M, et al. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy [J]. Clin Exp Immunol, 1982, 49(2): 419-425.
|
| 4 |
Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, et al. Charge and size of mesangial IgA in IgA nephropathy [J]. Kidney Int, 1985, 28(4): 666-671.
|
| 5 |
Moldoveanu Z, Wyatt RJ, Lee JY, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels [J]. Kidney Int, 2007, 71(11): 1148-1154.
|
| 6 |
Hiki Y, Iwase H, Kokubo T, et al. Association of asialo-galactosyl β1-3-N-acetylgalactosamine on the hinge with a conformational instability of Jacalin-reactive immunoglobulin A1 in immunoglobulin A nephropathy [J]. J Am Soc Nephrol, 1996, 7(6), 955-960.
|
| 7 |
Tomana M, Novak J, Julian BA, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies [J]. J Clin. Invest, 1999, 104(1): 73-81.
|
| 8 |
Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus [J]. J Clin Invest, 1980, 66(6): 1432-1436.
|
| 9 |
Novak J, Moldoveanu Z, Renfrow MB, et al. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells [J]. Contrib Nephrol, 2007, 157: 134-138.
|
| 10 |
Zhao N, Hou P, Lv J, et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression [J]. Kidney Int, 2012, 82(7): 790-796.
|
| 11 |
Tomana M, Kulhavy R, Mestecky J. Receptor-mediated binding and uptake of immunoglobulin A by human liver [J]. Gastroenterology, 1988, 94(3): 762-770.
|
| 12 |
Tomana M, Phillips JO, Kulhavy R, et al. Carbohydrate-mediated clearance of secretory IgA from the circulation [J]. Mol Immunol, 1985, 22(8): 887-892.
|
| 13 |
Feehally J, Farrall M, Boland A, et al. HLA has strongest association with IgA nephropathy in genome-wide analysis [J]. J Am Soc Nephrol, 2010, 21(10): 1791-1797.
|
| 14 |
Gharavi AG, Kiryluk K, Choi M, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy [J]. Nat Genet, 2011, 43(4): 321-327.
|
| 15 |
Yu XQ, Li M, Zhang H, et al. A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy [J]. Nat Genet, 2012, 44(2): 178-182.
|
| 16 |
Fennessy M, Hitman GA, Moore RH, et al. HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations [J]. Kidney Int, 1996, 49(2): 477-480.
|
| 17 |
Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)-6-type cytokine signaling and its regulation [J]. Biochem J, 2003, 374(Pt 1): 1-20.
|
| 18 |
Rostoker G, Rymer JC, Bagnard G, et al. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Sch？nlein purpura nephritis, and a potential target of immunoglobulin therapy [J] ? Clin Exp Immunol, 1998, 114(3): 468-476.
|
| 19 |
Suzuki H, Raska M, Yamada K, et al. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes [J]. J Biol Chem, 2014, 289(8): 5330-5339.
|
| 20 |
Reily C, Yamada K, Huang ZQ, et al. Abnormal STAT3 signaling enhances production of autoantigen in an autoimmune disease, IgA nephropathy [Abstract] [J]. J Am Soc Nephrol, 2013, 24: 20A.
|
| 21 |
Suzuki H, Moldoveanu Z, Hall S, et al. Cytokines regulate aberrant glycosylation of IgA1 in cell lines from patients with IgA nephropathy [Abstract] [J]. J Am Soc Nephrol, 2007, 18, 188A.
|
| 22 |
Yamada K, Huang ZQ, Raska M, et al. Effects of leukemia inhibitory factor and oncostatin M on IgA1-producing cells from patients with IgA nephropathy [Abstract] [J]. J Am Soc Nephrol, 2012, 23: 912A.
|
| 23 |
Stein JV, López-Fraga M, Elustondo FA, et al. APRIL modulates B and T cell immunity [J]. J Clin Invest, 2002, 109(12): 1587-1598.
|
| 24 |
McCarthy DD, Kujawa J, Wilson C, et al. Mice overexpressing BAFF develop a commensal flora-dependent, IgA associated nephropathy [J]. J Clin Invest, 2011, 121(10): 3991-4002.
|
| 25 |
Xin G, Shi W, Xu LX, et al. Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features [J]. J Nephrol, 2013, 26(4): 683-690.
|
| 26 |
Allen AC, Topham PS, Harper SJ, et al. Leukocyte β1, 3-galactosyltransferase activity in IgA nephropathy [J]. Nephrol Dial Transplant, 1997, 12(4): 701-706.
|
| 27 |
Greer MR, Barratt J, Harper SJ, et al. The nucleotide sequence of the IgA1 hinge region in IgA nephropathy [J]. Nephrol Dial Transplant, 1998, 13(8): 1980-1983.
|
| 28 |
Qin W, Zhong X, Fan JM, et al. External suppression causes the low expression of the Cosmc gene in IgA nephropathy [J] . Nephrol Dial Transplant, 2008, 23(5): 1608-1614.
|
| 29 |
Suzuki H, Moldoveanu Z, Hall S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1 [J]. J Clin Invest, 2008, 118(2): 629-639.
|
| 30 |
Xie LS, Qin W, Fan JM, et al. The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy [J]. Clin Invest Med, 2010, 33(1): 5-13.
|
| 31 |
Berger J, Yaneva H, Nabarra B, et al. Reccurence of mesangial deposition of IgA after renal transplantation [J]. Kidney Int, 1975, 7(4): 232-241.
|
| 32 |
Lai KN, Tang SC, Guh JY, et al. Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system [J]. J Am Soc Nephrol, 2003, 14(12): 3127-3137.
|
| 33 |
Chan LY, Leung JC, Tsang AW, et al. Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy [J]. Kidney Int, 2005, 67(2): 602-612.
|
| 34 |
Otani M, Nakata J, Kihara M, et al. O-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis [J]. J Am Soc Nephrol, 2012, 23(3): 438-446.
|
| 35 |
Maillard N, Wyatt RJ, Julian BA, et al. Current understanding of the role of complement in IgA nephropathy [J]. J Am Soc Nephrol, 2015, 26(7): 1503-1512.
|
| 36 |
Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease [J]. J Am Soc Nephrol, 2006, 17(6): 1724-1734.
|
| 37 |
Zhu L, Zhai YL, Wang FM, et al. Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy [J]. J Am Soc Nephrol, 2015, 26(5): 1195-1204.
|
| 38 |
Monteiro RC, Van De Winkel JG. IgA Fc receptors [J]. Annu Rev Immunol, 2003, 21: 177-204.
|
| 39 |
Lehoux S, Mi R, Aryal RP, et al. Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals [J]. Mol Cell Proteomics, 2014, 13(11): 3097-3113.
|